Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Clinical trial NCT00199979 · UNKNOWN

Trial details

NCT number: NCT00199979
Sponsor: MEDEX
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hiv Infection With Antiretroviral Therapy Indication CD4 Below 350/µL or Below 15%

Start date: 2005-04-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.